| Predicate |
Object |
| assignee |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_94089c2c1a928fa7bdb0efd4137846a4 |
| classificationCPCAdditional |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K38-00 |
| classificationCPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C12Y111-01015
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C12N9-0065
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P29-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P17-02
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P11-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P39-06
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-385 |
| classificationIPCAdditional |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K38-00 |
| classificationIPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P39-06
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-385
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07H21-02
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C12N9-08
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C12N9-02
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C12P21-06
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C12N15-00 |
| filingDate |
2003-11-05^^<http://www.w3.org/2001/XMLSchema#date> |
| grantDate |
2011-08-23^^<http://www.w3.org/2001/XMLSchema#date> |
| inventor |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_75c7b2e80ac0f3b12d30911511bc2547
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_4a1f6a652368f3c12c5436e54f6ea665
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_4ed7d947fe7078a0fa20a5cd9e4727b4
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_5691b21988807ebd7310b3cf7d9c59a6
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_3a95e55b22002003add5399bb887364b |
| publicationDate |
2011-08-23^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber |
US-8003345-B2 |
| titleOfInvention |
Antioxidant pharmaceutical compound, method for producing polypeptide and method of cure |
| abstract |
The invention relates to a pharmaceutical compound for antioxidant protection of cells, tissues and entire organism against hyperproduction of fee radicals. The inventive compound comprises an effective quantity of at least one antioxidant in the form of a main acting component. Said antioxidant is selected from a group consisting peroxiredoxine, a fragment thereof, dihydrolipoic acid and the combinations thereof with acceptable pharmaceutical additives. The inventive method for preventing and curing mammals consists in contacting the effective quantity of the compound with intercellular space of tissue, organ and entire mammal organism. Low toxicity of the compound makes it possible to increase the efficiency of treatment of multifactor actions on an organism, for example radiation, thermal, chemical burn, wounds and hurts as a result of disasters and fires. |
| isCitedBy |
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-8859235-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-2012164162-A1 |
| priorityDate |
2002-11-10^^<http://www.w3.org/2001/XMLSchema#date> |
| type |
http://data.epo.org/linked-data/def/patent/Publication |